Eva Arneric
Eva Arneric has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Adriano Polpo
School of Physics, Mathematics and Computing, University of Western Australia, Crawley, Western Australia, Australia
1 shared publication - Angela Jacques
Research Department, Perth Children’s Hospital, Child and Adolescent Health Service, Perth, WA 6009, Australia
1 shared publication - Colin Tang
Department of Radiation Oncology Sir Charles Gardiner Hospital Nedlands Western Australia Australia
1 shared publication - Dhaval Thakkar
Department of Respiratory Medicine Sir Charles Gairdner Hospital Perth Australia
1 shared publication - Jake Kendrick
School of Physics, Mathematics and Computing, University of Western Australia, Crawley, Australia
1 shared publication - Jeremy Croker
Department of Radiation Oncology, Sir Charles Gairdner Hospital , Perth, Western Australia
1 shared publication
Latest Publications
- Open Access
- 20 March 2026
- Published by Elsevier in SSRN Electronic Journal
Patient selection and workflow optimisation for fiducial-free 2-View tracking in CyberKnife lung stereotactic radiotherapy
PurposeThe CyberKnife® (CK) Synchrony® Xsight® Lung Tracking System (XLTS) enables non-invasive soft tissue-based respiratory tracking as an alternative to fiducial implantation for lung stereotactic body radiotherapy (SBRT). Patient selection has relied on clinician judgment, often resulting in unsuccessful simulations and treatment delays. This study evaluated fiducial-free CK simulation outcomes, identified predictors of successful 2-View tracking, and developed evidence-based patient selection framework.Methods and materialsThirty consecutive patients undergoing fiducial-free CK simulation between April 2022 and March 2024 were retrospectively analysed. Simulation outcomes were classified as 2-View, 1-View, or 0-View based on live X-ray image correlation. Tumour location, diameter, volume, density (Hounsfield units), X-ray technique, and axial position were assessed for association with successful 2-View tracking.ResultsSuccessful 2-View tracking was achieved in 33.3% of simulations, while 23.4% and 43.3% resulted in 1-View and 0-View outcomes, respectively. Simulation failure was more frequent in tumours <15 mm, centrally located lesions, or those adjacent to the diaphragm. Successful 2-View tracking was associated with larger tumour volume (mean 4.7 vs 1.6 cm3, p = 0.028) and higher maximum tumour density (67.5 vs 56.0 HU, p = 0.029).ConclusionsThis study evaluated fiducial-free CK simulation to support more consistent patient selection for lung SBRT. Tumour location, diameter, and density may help predict tracking success and reduce unsuccessful simulations. These findings provide a practical framework to guide fiducial use and lay the groundwork for future predictive models to identify, at an early stage, patients likely to require fiducial implantation at biopsy.
- 20 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessPatient selection and workflow optimisation for fiducial-free 2-View tracking in CyberKnife lung stereotactic radiotherapy
PurposeThe CyberKnife® (CK) Synchrony® Xsight® Lung Tracking System (XLTS) enables non-invasive soft tissue-based respiratory tracking as an alternative to fiducial implantation for lung stereotactic body radiotherapy (SBRT). Patient selection has relied on clinician judgment, often resulting in unsuccessful simulations and treatment delays. This study evaluated fiducial-free CK simulation outcomes, identified predictors of successful 2-View tracking, and developed evidence-based patient selection framework.Methods and materialsThirty consecutive patients undergoing fiducial-free CK simulation between April 2022 and March 2024 were retrospectively analysed. Simulation outcomes were classified as 2-View, 1-View, or 0-View based on live X-ray image correlation. Tumour location, diameter, volume, density (Hounsfield units), X-ray technique, and axial position were assessed for association with successful 2-View tracking.ResultsSuccessful 2-View tracking was achieved in 33.3% of simulations, while 23.4% and 43.3% resulted in 1-View and 0-View outcomes, respectively. Simulation failure was more frequent in tumours <15 mm, centrally located lesions, or those adjacent to the diaphragm. Successful 2-View tracking was associated with larger tumour volume (mean 4.7 vs 1.6 cm3, p = 0.028) and higher maximum tumour density (67.5 vs 56.0 HU, p = 0.029).ConclusionsThis study evaluated fiducial-free CK simulation to support more consistent patient selection for lung SBRT. Tumour location, diameter, and density may help predict tracking success and reduce unsuccessful simulations. These findings provide a practical framework to guide fiducial use and lay the groundwork for future predictive models to identify, at an early stage, patients likely to require fiducial implantation at biopsy.